Predictors of difficulty when discontinuing postmenopausal hormone therapy

Obstetrics and Gynecology

Volumn 102, Issue 6, 2003, Pages 1233-1239

  Grady, Deborah ^a   Ettinger, Bruce ^b   Tosteson, Anna N A ^b   Pressman, Alice ^b   Macer, Judith L ^b  

^a Women's Hlth Clin Research Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HEALTH PROMOTION; HEALTH SURVEY; HIP FRACTURE; HORMONAL THERAPY; HUMAN; HYSTERECTOMY; INTERVIEW; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREDICTION; PRIORITY JOURNAL; RANDOMIZATION; SPINE FRACTURE; TELEPHONE; TREATMENT WITHDRAWAL; WITHDRAWAL SYNDROME;

EID: 0344255781     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.obstetgynecol.2003.09.025     Document Type: Article

References (12)

1. Hulley S., Furberg C., Barrett-Connor E., Cauley J., Grady D., Haskell W., et al. Noncardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA. 288:2002;58-66.
2. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA. 288:2002;321-333.
3. Shumaker S.A., Legault C., Rapp S.R., Thal L., Wallace R.B., Ockene J.K., et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women The Women's Health Initiative Memory Study: A randomized controlled trial . JAMA. 289:2003;2651-2662.
4. American College of Obstetrics and Gynecology. Questions and answers on hormone therapy. Available at: http://www.acog.com/from_home/publications/ press_releases/nr08-30-02.cfm. Accessed June 15, 2003.
5. Amended report from the NAMS Advisory Panel on Postmenopausal Hormone Therapy. Menopause. 10:2003;6-12.
6. Colata G. Rush to fill void in menopause-drug market. New York Times. September 1, 2002, Section 1, page 1.
7. Ettinger B, Grady D, Tosteson AN, Pressman A, Macer JL. Effect of Women's Health Initiative findings on women's decisions to discontinue postmenopausal hormone therapy. Obstet Gynecol 2003;6:1225-32.
8. Tosteson AN, Grove MR, Hammond CS, Moncur MM, Roy GJ, Herbert GM. Early discontinuation of osteoporosis treatment among women with low bone mineral density. Am J Med. In press 2003.
9. National Committee for Quality Assurance. Management of menopause: Informed choices. Available at: http://www.ncqa.org/somc2001/menopause/ somc_2001_mom.html. Accessed June 15, 2003.
10. Ettinger B., Li D.K., Klein R. Continuation of postmenopausal hormone replacement therapy Comparison of cyclic versus continuous combined schedules . Menopause. 3:1996;185-189.
11. Stearns V., Ullmer L., Lopez J.F., Smith Y., Isaacs C., Hayes D.F. Hot flushes. Lancet. 360:2002;1851-1861.
12. Freedman R.R., Woodward S. Behavioral treatment of menopausal hot flushes Evaluation by ambulatory monitoring . Am J Obstet Gynecol. 167:1992;436-439.